Company Overview of Kiadis Pharma N.V.
Kiadis Pharma N.V. researches, develops, and commercializes cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. Its products provide for Allodepleted T-cell ImmunotheRapeutics (ATIR). The company offers ATIR101 that addresses the risks and limitations of current hematopoietic stem cell transplantation treatments in blood cancers. The company also develops ATIR201 for inherited blood disorders with an initial focus on thalassemia. Kiadis Pharma N.V. was founded in 1997 and is headquartered in Amsterdam-Duivendrecht, the Netherlands.
Amsterdam-Duivendrecht, 1114 AA
Founded in 1997
31 20 314 0250
31 20 314 0251
Key Executives for Kiadis Pharma N.V.
Kiadis Pharma N.V. Key Developments
Similar Private Companies By Industry
|Fresenius Hemocare B.V.||Europe|
|Isotron Nederland B.V.||Europe|
|Synthon Holding B.V.||Europe|
|Diosynth Holding B.V.||Europe|
|Sanofi-aventis Netherlands B.V.||Europe|
Recent Private Companies Transactions
October 30, 2014
To contact Kiadis Pharma N.V., please visit www.kiadis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.